ES557374A0 - Un procedimiento para preparar una sal fisiologicamente aceptable de activador de plasminogeno de tejido (t-pa). - Google Patents

Un procedimiento para preparar una sal fisiologicamente aceptable de activador de plasminogeno de tejido (t-pa).

Info

Publication number
ES557374A0
ES557374A0 ES557374A ES557374A ES557374A0 ES 557374 A0 ES557374 A0 ES 557374A0 ES 557374 A ES557374 A ES 557374A ES 557374 A ES557374 A ES 557374A ES 557374 A0 ES557374 A0 ES 557374A0
Authority
ES
Spain
Prior art keywords
preparing
procedure
acceptable salt
physiologically acceptable
plasminogen activator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557374A
Other languages
English (en)
Other versions
ES8802439A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858513358A external-priority patent/GB8513358D0/en
Priority claimed from GB858521705A external-priority patent/GB8521705D0/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES8802439A1 publication Critical patent/ES8802439A1/es
Publication of ES557374A0 publication Critical patent/ES557374A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES557374A 1985-05-28 1987-02-10 Un procedimiento para preparar una sal fisiologicamente aceptable de activador de plasminogeno de tejido (t-pa). Expired ES8802439A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858513358A GB8513358D0 (en) 1985-05-28 1985-05-28 Formulation
GB858521705A GB8521705D0 (en) 1985-08-31 1985-08-31 Formulation

Publications (2)

Publication Number Publication Date
ES8802439A1 ES8802439A1 (es) 1988-06-01
ES557374A0 true ES557374A0 (es) 1988-06-01

Family

ID=26289290

Family Applications (2)

Application Number Title Priority Date Filing Date
ES555353A Expired ES8800601A1 (es) 1985-05-28 1986-05-27 Un procedimiento para preparar una formulacion farmaceutica liofilizada de activador de plasminogeno de tejidro (t-pa)
ES557374A Expired ES8802439A1 (es) 1985-05-28 1987-02-10 Un procedimiento para preparar una sal fisiologicamente aceptable de activador de plasminogeno de tejido (t-pa).

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES555353A Expired ES8800601A1 (es) 1985-05-28 1986-05-27 Un procedimiento para preparar una formulacion farmaceutica liofilizada de activador de plasminogeno de tejidro (t-pa)

Country Status (22)

Country Link
US (2) US4929444A (es)
JP (1) JPH0759517B2 (es)
AU (1) AU567236B2 (es)
BE (1) BE904830A (es)
CA (1) CA1300008C (es)
CH (1) CH665356A5 (es)
DE (1) DE3617752A1 (es)
DK (1) DK163173C (es)
ES (2) ES8800601A1 (es)
FI (1) FI85335C (es)
FR (1) FR2583984B1 (es)
GB (1) GB2176702B (es)
GR (1) GR861366B (es)
HU (1) HU195733B (es)
IL (1) IL78938A (es)
IT (1) IT1191926B (es)
LU (1) LU86444A1 (es)
NL (1) NL8601355A (es)
NO (1) NO171345C (es)
NZ (1) NZ216307A (es)
PT (1) PT82646B (es)
SE (1) SE462016B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8601354A (nl) * 1985-05-28 1986-12-16 Wellcome Found Nieuwe samenstelling.
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
US5034225A (en) * 1985-12-17 1991-07-23 Genentech Inc. Stabilized human tissue plasminogen activator compositions
US4976959A (en) * 1986-05-12 1990-12-11 Burroughs Wellcome Co. T-PA and SOD in limiting tissue damage
DK237187A (da) * 1986-05-12 1987-11-13 Wellcome Found Farmaceutisk anvendelse af t-pa
GB8619098D0 (en) * 1986-08-05 1986-09-17 Wellcome Found Combination
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5342616A (en) * 1988-06-20 1994-08-30 The Wellcome Foundation Limited Method of administering tissue plasminogen activator
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
DE3835350A1 (de) * 1988-10-17 1990-04-19 Boehringer Mannheim Gmbh Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3942142A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von glykosyliertem t-pa
WO1992011866A1 (en) * 1991-01-14 1992-07-23 Duke University LAMININ SEQUENCE AS tPA ACTIVATOR
AU664469B2 (en) * 1992-06-03 1995-11-16 Genentech Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
CN1202932A (zh) * 1995-10-23 1998-12-23 儿童医学中心公司 治疗用抗血管生成的组合物和方法
WO1997023500A1 (en) * 1995-12-13 1997-07-03 The Children's Medical Center Corporation Endothelial cell proliferation inhibitor and method of use
US6139838A (en) * 1996-09-06 2000-10-31 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Tissue plasminogen activator medicinal composition
US20030077682A1 (en) * 2001-09-07 2003-04-24 Hung Paul Porwen Human tissue urokinase type plasminogen activator formulation
US20040091465A1 (en) * 2002-06-26 2004-05-13 Zachary Yim Therapeutic antiangiogenic compositions and methods
US20050053980A1 (en) * 2003-06-20 2005-03-10 Illumina, Inc. Methods and compositions for whole genome amplification and genotyping
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
CA2605631A1 (en) * 2005-04-20 2006-10-26 Fred Hutchinson Cancer Research Center Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
FR2252842B1 (es) * 1973-12-03 1977-11-04 Fabre Sa Pierre
DE3015699C2 (de) * 1979-04-26 1982-07-15 Asahi Kasei Kogyo K.K., Osaka Herstellung eines Plasminogen-Aktivators
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
WO1984001714A1 (en) * 1982-10-29 1984-05-10 Mitsui Toatsu Chemicals Novel plasminogen activator, process for its preparation, and thrombolytic drug containing the same
AU554862B2 (en) * 1982-12-14 1986-09-04 Implico B.V. Plasminogen activator isolated by affinity chromatography
NZ206699A (en) * 1982-12-30 1989-08-29 Bio Response Inc Process for the production of serum independent cell lines
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
DE3439980A1 (de) * 1984-11-02 1986-05-07 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung sowie pasteurisierung von urokinase
EP0201153A3 (en) * 1985-02-09 1987-10-07 Beecham Group Plc Modified enzyme and process for its preparation
GB8513358D0 (en) * 1985-05-28 1985-07-03 Wellcome Found Formulation
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法

Also Published As

Publication number Publication date
FR2583984A1 (fr) 1987-01-02
DK163173C (da) 1992-06-22
US4968617A (en) 1990-11-06
CH665356A5 (de) 1988-05-13
GB8612780D0 (en) 1986-07-02
ES8800601A1 (es) 1987-11-16
SE8602405L (sv) 1986-11-29
AU567236B2 (en) 1987-11-12
DE3617752C2 (es) 1988-06-30
ES555353A0 (es) 1987-11-16
ES8802439A1 (es) 1988-06-01
GB2176702B (en) 1989-07-05
IL78938A (en) 1993-02-21
CA1300008C (en) 1992-05-05
IL78938A0 (en) 1986-09-30
DK246786D0 (da) 1986-05-27
PT82646A (en) 1986-06-01
FI862227A0 (fi) 1986-05-27
NZ216307A (en) 1989-10-27
HUT41638A (en) 1987-05-28
GR861366B (en) 1986-09-29
SE462016B (sv) 1990-04-30
SE8602405D0 (sv) 1986-05-27
IT8648065A0 (it) 1986-05-27
FI85335B (fi) 1991-12-31
NO171345B (no) 1992-11-23
US4929444A (en) 1990-05-29
DK246786A (da) 1986-11-29
DE3617752A1 (de) 1986-12-04
GB2176702A (en) 1987-01-07
NO171345C (no) 1993-03-03
PT82646B (pt) 1989-01-30
FI85335C (fi) 1992-04-10
NO862096L (no) 1986-12-01
DK163173B (da) 1992-02-03
BE904830A (fr) 1986-11-27
FI862227A (fi) 1986-11-29
FR2583984B1 (fr) 1989-06-02
IT1191926B (it) 1988-03-31
LU86444A1 (fr) 1986-12-05
HU195733B (en) 1988-07-28
JPH06183995A (ja) 1994-07-05
NL8601355A (nl) 1986-12-16
AU5796486A (en) 1986-12-04
JPH0759517B2 (ja) 1995-06-28

Similar Documents

Publication Publication Date Title
ES557374A0 (es) Un procedimiento para preparar una sal fisiologicamente aceptable de activador de plasminogeno de tejido (t-pa).
ES555352A0 (es) Un procedimiento para preparar una solucion parenteral de activador de plasminogeno de tejido (t-pa)
ES551770A0 (es) Un procedimiento para preparar activador de plasminogeno de tipo tejido modificado.
ES553651A0 (es) Un procedimiento para preparar un activante de plasminogeno.
ES555289A0 (es) Procedimiento para preparar una composicion efervescente de rapida disolucion de un agente terapeutico
AU6806487A (en) Tissue plasminogen activator
MX7663E (es) Un procedimiento para preparar un derivado de una enzima fibrinolitica
EP0238551A4 (en) METHODS OF RECOVERING A TISSUE PLASMINOGEN ACTIVATOR.
BG44379A3 (en) Method for preparing of 9- chlor- 1, 5- benzothiazepine derivatives
AU6180486A (en) Novel tissue plasminogen activator derivatives
ES557690A0 (es) Un procedimiento para preparar un derivado de 2,3-dihidro-1-h-indeno y una sal del mismo
DK163639C (da) Synergistisk farmaceutisk blanding af vaevsplasminogenaktivator og et prostaglandin, farmaceutisk praeparat indeholdende blandingen samt anvendelse af blandingen til fremstilling af et laegemiddel mod blodpropper
AU3838189A (en) Tissue plasminogen activator analogues having improved activity
EP0208486A3 (en) Process for producing tissue plasminogen activator
DK369686A (da) Fremgangsmaade til oprensning af vaevsplasminogenaktivator
NZ219920A (en) Purification of t.p.a. (tissue plasminogen activator)
ZA863956B (en) Pharmaceutical formulations containing tissue plasminogen activator
NL189334C (nl) Therapeutisch preparaat dat catecholderivaten bevat.
IL78450A0 (en) Agent containing tissue plasminogen activator(t-pa)
AU7090787A (en) Tissue plasminogen activator
GB8815245D0 (en) New tissue plasminogen activator
KR0135314B1 (en) Tissue plasminogen activator analogs having modified growth
EP0358274A3 (en) Method for purifying tissue plasminogen activator
AU608232C (en) Modified tissue plasminogen activator
AU563031B2 (en) Human tissue plasminogen activator

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970612